# Multimodal Assessment of Cannabinoid Target Engagement in Adults With Obsessive-Compulsive Disorder

> **NCT04880278** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **New York State Psychiatric Institute**

## Conditions studied

- Obsessive-Compulsive Disorder

## Interventions

- **DRUG:** Nabilone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04880278
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-03-01
- **Primary completion:** 2024-05-08
- **Final completion:** 2024-05-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The Principal Investigator is no longer at the Institution and a request for early termination of the grant supporting the study was submitted to NIH.
- **Last updated:** 2024-05-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04880278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04880278, "Multimodal Assessment of Cannabinoid Target Engagement in Adults With Obsessive-Compulsive Disorder". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT04880278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*